W. Michael Flanagan sold $416K of Avidity Biosciences (RNA)

Executed Dec 18 2024, disclosed Dec 19 2024, 1 day later.

Value, as filed

$416K

12,742 sh × $32.66

Executed

Dec 18 2024

the trade date, as filed

Disclosed

Dec 19 2024

1 day after the trade

Return, 21 sessionsiFrom the disclosed entry session; derived

–

purchases only

Returns are measured on stock purchases only.

The filer

WF W. Michael Flanagan Chief Scientific Officer profile →

W. Michael Flanagan (Chief Scientific Officer) filed 2 Form 4 reports in the trailing twelve months (0 purchases, 2 sales), most often in RNA. The largest single filing was $473K of RNA (6,534 sh across 2 lots, as filed), executed Jan 21.

The name

RNA RNA RNA · 61 filings in 24 months ticker → Insider filings, newest first→ View the original filing at www.sec.gov→

Other filings by W. Michael Flanagan in RNA

RNASALE Avidity Biosciences, Inc. $473K
6,534 sh across 2 lots
Exec Jan 21
Filed Jan 23 · 5:30 PM ET RNASALE Avidity Biosciences, Inc. $171K
2,373 sh × $72.23
Exec Jan 7
Filed Jan 9 · 5:30 PM ET RNASALE Avidity Biosciences, Inc. $779K
20,000 sh × $38.94
Exec Sep 11 2025
Filed Sep 12 2025 · 5:30 PM ET RNASALE Avidity Biosciences, Inc. $658K
20,000 sh × $32.88
Exec Jun 11 2025
Filed Jun 12 2025 · 5:30 PM ET RNASALE Avidity Biosciences, Inc. $366K
11,780 sh × $31.06
Exec Mar 20 2025
Filed Mar 21 2025 · 5:30 PM ET RNASALE Avidity Biosciences, Inc. $603K
20,000 sh × $30.13
Exec Mar 11 2025
Filed Mar 12 2025 · 5:30 PM ET RNASALE Avidity Biosciences, Inc. $110K
3,860 sh × $28.60
Exec Jan 21 2025
Filed Jan 23 2025 · 5:30 PM ET RNASALE Avidity Biosciences, Inc. $858K
24,000 sh × $35.77
Exec Dec 11 2024
Filed Dec 13 2024 · 5:30 PM ET